Lilly cuts insulin prices by 70%, caps out-of-pocket costs at $35 per month
Eli Lilly and Company (NYSE: LLY) today announced cut in prices of 70% for its most commonly prescribed insulins and an expansion of its Insulin Value Program that caps patient out-of-pocket costs…